{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:16:42Z","timestamp":1789143402189,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503625"],"award-info":[{"award-number":["82503625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272722"],"award-info":[{"award-number":["82272722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ60603"],"award-info":[{"award-number":["2025JJ60603"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M771485"],"award-info":[{"award-number":["2025M771485"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117179","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:28:43Z","timestamp":1784842123000},"page":"117179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PLIN3 knockdown enhances T cell-mediated cytotoxicity in non-small cell lung cancer via autophagy-dependent PD-L1 degradation"],"prefix":"10.1016","volume":"187","author":[{"given":"Hanqiong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.117179_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10454","key":"10.1016\/j.intimp.2026.117179_bb0010","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-024-01581-2","article-title":"Dual blockade immunotherapy targeting PD-1\/PD-L1 and CTLA-4 in lung cancer","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0030","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/s41598-019-40748-7","article-title":"Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1\/PD-L1 inhibitors","volume":"9","author":"Song","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2026.117179_bb0035","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jtho.2025.03.033","article-title":"Cemiplimab monotherapy for first-line treatment of patients with advanced NSCLC with PD-L1 expression of 50% or higher: five-year outcomes of EMPOWER-Lung 1","volume":"20","author":"Kilickap","year":"2025","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117179_bb0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s13238-018-0593-9","article-title":"Phosphorylation of PLIN3 by AMPK promotes dispersion of lipid droplets during starvation","volume":"10","author":"Zhu","year":"2019","journal-title":"Protein Cell"},{"issue":"2","key":"10.1016\/j.intimp.2026.117179_bb0045","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7150\/thno.49384","article-title":"ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.intimp.2026.117179_bb0050","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1002\/hep.32048","article-title":"A mammalian target of rapamycin-perilipin 3 (mTORC1-Plin3) pathway is essential to activate lipophagy and protects against hepatosteatosis","volume":"74","author":"Garcia-Macia","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2026.117179_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109451","article-title":"RalA and PLD1 promote lipid droplet growth in response to nutrient withdrawal","volume":"36","author":"Hussain","year":"2021","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.intimp.2026.117179_bb0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.urolonc.2018.04.006","article-title":"PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma","volume":"36","author":"Wang","year":"2018","journal-title":"Urol. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117179_bb0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00262-024-03659-9","article-title":"Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma","volume":"73","author":"He","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"20","key":"10.1016\/j.intimp.2026.117179_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012533","article-title":"Lipid droplets in lung cancers are crucial for the cell growth and starvation survival","volume":"23","author":"Lung","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.117179_bb0075","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.7150\/jca.53119","article-title":"Co-expression of PD-L1 and HIF-1alpha predicts poor prognosis in patients with non-small cell Lung Cancer after surgery","volume":"12","author":"Zheng","year":"2021","journal-title":"J. Cancer"},{"issue":"16","key":"10.1016\/j.intimp.2026.117179_bb0080","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1002\/cam4.2579","article-title":"Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection","volume":"8","author":"Zheng","year":"2019","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0085","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s41467-022-28479-2","article-title":"EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2026.117179_bb0090","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117179_bb0095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/15548627.2021.1926656","article-title":"Autophagy and ALS: mechanistic insights and therapeutic implications","volume":"18","author":"Chua","year":"2022","journal-title":"Autophagy"},{"issue":"10","key":"10.1016\/j.intimp.2026.117179_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25102352","article-title":"Mechanisms regulating the UPS-ALS crosstalk: the role of proteaphagy","volume":"25","author":"Quinet","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12943-023-01885-w","article-title":"Exploiting innate immunity for cancer immunotherapy","volume":"22","author":"Yi","year":"2023","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2026.117179_bb0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117179_bb0115","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/2159-8290.CD-20-1209","article-title":"Development of immunotherapy combination strategies in Cancer","volume":"11","author":"Yap","year":"2021","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.intimp.2026.117179_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40259-024-00700-2","article-title":"Primary and acquired resistance to immunotherapy with checkpoint inhibitors in NSCLC: from bedside to bench and back","volume":"39","author":"Mariniello","year":"2025","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-024-01934-y","article-title":"Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117179_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist. Updat."},{"issue":"5","key":"10.1016\/j.intimp.2026.117179_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","article-title":"Recent advances in targeting autophagy in cancer","volume":"44","author":"Jain","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2026.117179_bb0145","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12943-025-02277-y","article-title":"Autophagy in tumor immune escape and immunotherapy","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117179_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100966","article-title":"Moments in autophagy and disease: past and present","volume":"82","author":"Wen","year":"2021","journal-title":"Mol. Asp. Med."},{"issue":"16","key":"10.1016\/j.intimp.2026.117179_bb0165","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMra2022774","article-title":"Autophagy in human diseases","volume":"383","author":"Mizushima","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.117179_bb0170","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2023.12.015","article-title":"Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"issue":"29","key":"10.1016\/j.intimp.2026.117179_bb0175","doi-asserted-by":"crossref","first-page":"18910","DOI":"10.1021\/acsnano.4c01157","article-title":"Development of granzyme B-targeted smart positron emission tomography probes for monitoring tumor early response to immunotherapy","volume":"18","author":"Fu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.117179_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104420","article-title":"Histone deacetylases inhibitor chidamide synergizes with humanized PD1 antibody to enhance T-cell chemokine expression and augment Ifn-gamma response in NK-T cell lymphoma","volume":"87","author":"Wen","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.intimp.2026.117179_bb0185","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1038\/s41467-021-24769-3","article-title":"NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:03:18Z","timestamp":1789142598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S1567576926010258"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117179","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLIN3 knockdown enhances T cell-mediated cytotoxicity in non-small cell lung cancer via autophagy-dependent PD-L1 degradation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117179"}}